Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
T.CD4_Treg.APC_interactive: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 3,777 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IL2RB levels | PROLV001070 | 61.26 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 2 | Hyperthyroidism | ENDOC000020 | 45.62 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 3 | Reimbursement for rheumatic disease | IMMUN000042 | 45.02 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 4 | Hyperthyroidism, autoimmune | IMMUN000014 | 41.43 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 5 | Hypothyroidism, autoimmune | IMMUN000015 | 40.66 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 6 | Papulosquamous disorder | DERMA000015 | 40.12 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 7 | KLRB1 levels | PROLV001161 | 39.60 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 8 | TNFRSF8 levels | PROLV002073 | 38.90 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 9 | Medication, Crohn disease | IMMUN000081 | 38.44 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 10 | CD5/TNFRSF9 ratio | PRORT000468 | 37.73 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 11 | PAG1 levels | PROLV001487 | 37.67 | Protein levels | Lymphocyte | 60 | 4 | 18 | 30 | |
| 12 | Dissociative disorder | PSYCH000012 | 35.84 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 13 | Autoimmune disease | IMMUN000023 | 35.66 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 14 | Graves disease | IMMUN000027 | 35.22 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 15 | SKAP1 levels | PROLV001872 | 34.96 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 16 | CRTAM/FCRL6 ratio | PRORT000768 | 34.59 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 17 | Immune cell marker, CD8 T cell | HEMAT000023 | 34.19 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 18 | ITGAL levels | PROLV001108 | 34.17 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 19 | Contact dermatitis | DERMA000007 | 33.09 | Dermatologic | Lymphocyte | 10 | 2 | 14 | 16 | |
| 20 | CD48/CRTAM ratio | PRORT000463 | 33.05 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 21 | Polyarthropathy | MSKEL000019 | 32.95 | Musculoskeletal | Lymphocyte | 65 | 2 | 13 | 23 | |
| 22 | Hypothyroidism | ENDOC000021 | 32.14 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 23 | CALCOCO1/TJAP1 ratio | PRORT000303 | 31.14 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 24 | CD160/KLRB1 ratio | PRORT000377 | 30.81 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 25 | MAVS/TBL1X ratio | PRORT001501 | 30.77 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 26 | Oral health conditions, none | DENTA000009 | 30.66 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 27 | FCRL6 levels | PROLV000787 | 30.47 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 28 | Skin eruption | DERMA000027 | 30.20 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 29 | HEXIM1/TBL1X ratio | PRORT001280 | 30.20 | Protein ratios | Myeloid | 4 | 3 | 12 | 30 | |
| 30 | Rheumatoid arthritis, RA | IMMUN000019 | 30.00 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 31 | Dermatitis and eczema | DERMA000008 | 29.98 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 32 | Monoclonal gammopathy | HEMAT000041 | 29.96 | Hematologic | B / plasma cell | 2 | 4 | 15 | 28 | |
| 33 | Medication, thyroid | ENDOC000002 | 29.91 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 34 | Pregnancy complication, preterm labour | REPRO000034 | 29.90 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 35 | Allergic disease | IMMUN000003 | 29.77 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 36 | HLAE/IL15 ratio | PRORT001287 | 29.69 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 37 | IL15/IL18BP ratio | PRORT001342 | 29.34 | Protein ratios | Lymphocyte | 14 | 2 | 11 | 22 | |
| 38 | CDSN/WFDC12 ratio | PRORT000585 | 29.25 | Protein ratios | Lymphocyte | 41 | 3 | 12 | 32 | |
| 39 | IL2RA levels | PROLV001069 | 29.08 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 40 | PAFAH1B3 levels | PROLV001486 | 29.01 | Protein levels | Lymphocyte | 45 | 2 | 17 | 18 | |
| 41 | Myasthenia gravis | IMMUN000035 | 28.49 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 42 | GZMH levels | PROLV000949 | 28.06 | Protein levels | Lymphocyte | 95 | 2 | 13 | 29 | |
| 43 | IL15 levels | PROLV001048 | 27.07 | Protein levels | Lymphocyte | 114 | 2 | 12 | 20 | |
| 44 | CRTAM/VCAM1 ratio | PRORT000775 | 26.86 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 45 | CC2D1A/STAMBP ratio | PRORT000328 | 26.15 | Protein ratios | Lymphocyte | 1 | 1 | 15 | 21 | |
| 46 | PDCD1 levels | PROLV001515 | 26.09 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 47 | Psoriatic arthritis | IMMUN000040 | 26.02 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 48 | Orbital disorder | OPHTH000021 | 25.84 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 49 | Lymphocyte | HEMAT000024 | 25.52 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 50 | Nutritional and metabolic symptoms | METBL000016 | 25.15 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 51 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 24.02 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 52 | CD244/CRTAM ratio | PRORT000406 | 23.91 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 53 | CD5 levels | PROLV000344 | 23.76 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 54 | Medical conditions, allergy etc, none | MISCL000026 | 23.74 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 55 | TIGIT levels | PROLV002034 | 23.59 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 56 | ATP5IF1/METAP1D ratio | PRORT000160 | 22.47 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 57 | Household income | SOCIO000026 | 22.38 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 58 | GZMA/GZMH ratio | PRORT001258 | 22.06 | Protein ratios | Lymphocyte | 23 | 2 | 12 | 23 | |
| 59 | IL2RA/NCR1 ratio | PRORT001351 | 22.05 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 60 | EDAR/LAT2 ratio | PRORT000973 | 21.93 | Protein ratios | Myeloid | 1 | 5 | 15 | 23 | |
| 61 | CRTAM/TNFRSF9 ratio | PRORT000774 | 21.64 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 62 | Thyroid peroxidase antibodies | IMMUN000045 | 21.25 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 63 | PPP1R2/TBL1X ratio | PRORT001706 | 21.22 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 64 | SH2B3/TBL1X ratio | PRORT001784 | 20.99 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 65 | Thyroid disorder | ENDOC000023 | 20.92 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 66 | CRTAM/LY9 ratio | PRORT000772 | 20.85 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 67 | GNLY levels | PROLV000905 | 20.74 | Protein levels | Lymphocyte | 91 | 2 | 14 | 32 | |
| 68 | ANP32B levels | PROLV000102 | 20.68 | Protein levels | Hepatocyte | 2 | 1 | 7 | 18 | |
| 69 | MZB1 levels | PROLV001366 | 20.63 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 70 | IL15/NCR1 ratio | PRORT001344 | 20.00 | Protein ratios | Lymphocyte | 32 | 2 | 9 | 31 | |
| 71 | Diabetes, type 1 | IMMUN000012 | 19.88 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 72 | SIT1 levels | PROLV001871 | 19.69 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 73 | Pulmonary nodule | RESPI000018 | 19.12 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 74 | Medication, bone metabolism | MSKEL000025 | 19.09 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 75 | Nasal polyp | RESPI000037 | 18.80 | Respiratory | Lymphocyte | 11 | 2 | 11 | 20 | |
| 76 | Multiple sclerosis | IMMUN000034 | 18.74 | Immunologic | Lymphocyte | 56 | 2 | 16 | 23 | |
| 77 | ZNF830 levels | PROLV002212 | 18.65 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 78 | Primary biliary cholangitis, PBC | IMMUN000017 | 18.61 | Immunologic | Lymphocyte | 91 | 3 | 13 | 9 | |
| 79 | Drug poisoning | MISCL000036 | 18.51 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 80 | Heme malignancy, Lymphoid | MALIG000043 | 18.45 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 81 | Stimulant use disorder | PSYCH000048 | 18.32 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 82 | Lymphangioleiomyomatosis | RESPI000014 | 18.24 | Respiratory | Muscle / cardiac | 0 | 3 | 7 | 25 | |
| 83 | NHLRC3 levels | PROLV001403 | 18.19 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 84 | CD244/FCRL6 ratio | PRORT000408 | 18.16 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 85 | Congenital malformation | REPRO000003 | 18.03 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 86 | Pain, neck | MSKEL000040 | 18.02 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 87 | LTA levels | PROLV001239 | 18.02 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 88 | Cervical intraepithelial lesion | REPRO000002 | 18.01 | Reproductive | Lymphocyte | 23 | 2 | 11 | 25 | |
| 89 | Infective dermatitis | DERMA000012 | 17.99 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 90 | FCRL5/LY96 ratio | PRORT001134 | 17.92 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 91 | FUT8/TNFSF14 ratio | PRORT001192 | 17.90 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 92 | Glucose regulation disorder | METBL000038 | 17.89 | Metabolic | Lymphocyte | 36 | 2 | 5 | 17 | |
| 93 | Thyrotoxicosis | ENDOC000024 | 17.78 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 94 | PRG3 levels | PROLV001629 | 17.68 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 95 | CLC levels | PROLV000443 | 17.41 | Protein levels | Lymphocyte | 65 | 3 | 19 | 17 | |
| 96 | Stevens-Johnson syndrome, SJS | IMMUN000001 | 17.41 | Immunologic | Lymphocyte | 3 | 2 | 10 | 28 | |
| 97 | Lichen disorder | DERMA000013 | 17.36 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 98 | Chalazion | OPHTH000017 | 17.32 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 99 | Eosinophil | HEMAT000030 | 17.14 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 100 | Nephritic syndrome | NEPHR000009 | 17.02 | Nephrourologic | Lymphocyte | — | 2 | 9 | 21 | |
| 101 | Psoriasis | IMMUN000039 | 17.00 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 102 | CD69/EDAR ratio | PRORT000491 | 16.97 | Protein ratios | Myeloid | 21 | 4 | 11 | 22 | |
| 103 | Social activity, none | SOCIO000018 | 16.90 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 104 | TPSAB1 levels | PROLV002099 | 16.77 | Protein levels | Lymphocyte | 33 | 2 | 14 | 25 | |
| 105 | PLAT levels | PROLV001571 | 16.70 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 106 | LY6D/WFDC12 ratio | PRORT001470 | 16.67 | Protein ratios | Myeloid | 14 | 2 | 17 | 20 | |
| 107 | Coeliac disease | IMMUN000026 | 16.63 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 108 | Gut microbial abundance, Chromatiales | GASTR000024 | 16.57 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 109 | EPO/TFRC ratio | PRORT001040 | 16.09 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 110 | MAP2K6/TBL1X ratio | PRORT001487 | 16.03 | Protein ratios | Myeloid | 10 | 4 | 12 | 28 | |
| 111 | Atopic dermatitis | DERMA000006 | 16.02 | Dermatologic | Lymphocyte | 115 | 2 | 13 | 11 | |
| 112 | CPXM1/HBEGF ratio | PRORT000733 | 16.01 | Protein ratios | Myeloid | 44 | 4 | 11 | 22 | |
| 113 | IL5RA/TNFRSF13B ratio | PRORT001352 | 15.96 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 114 | GZMB/IL15 ratio | PRORT001263 | 15.95 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 115 | ATP5IF1/LYN ratio | PRORT000159 | 15.91 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 116 | Respiratory disease | RESPI000004 | 15.88 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 117 | CD6 levels | PROLV000349 | 15.78 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 118 | Medication, insulin therapy | METBL000027 | 15.68 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 119 | Cancer, Urinary tract | MALIG000033 | 15.67 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 120 | Frailty, metabolic problems | METBL000011 | 15.66 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 121 | CRTAM/ICAM3 ratio | PRORT000770 | 15.56 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 122 | Muscular dystrophy | MSKEL000028 | 15.50 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 123 | CD160/CXCL16 ratio | PRORT000376 | 15.48 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 124 | EDAR/ERBIN ratio | PRORT000967 | 15.27 | Protein ratios | Myeloid | 31 | 4 | 15 | 24 | |
| 125 | CD8A levels | PROLV000361 | 14.98 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 126 | SUGT1/TBL1X ratio | PRORT001822 | 14.78 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 127 | KLRF1 levels | PROLV001163 | 14.64 | Protein levels | Lymphocyte | 134 | 3 | 14 | 15 | |
| 128 | IBD-Crohn disease | IMMUN000029 | 14.48 | Immunologic | Myeloid | 279 | 4 | 19 | 18 | |
| 129 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 14.36 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 130 | PDCD1/TNFRSF8 ratio | PRORT001630 | 14.32 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 131 | GZMA/GZMB ratio | PRORT001257 | 14.19 | Protein ratios | Lymphocyte | 44 | 2 | 12 | 21 | |
| 132 | Vitamin B12 deficiency anaemia | HEMAT000014 | 14.13 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 133 | SH2D1A levels | PROLV001852 | 14.12 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 134 | CAPG levels | PROLV000262 | 14.11 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 135 | FCRL3 levels | PROLV000785 | 14.09 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 136 | GOPC/IRAK4 ratio | PRORT001224 | 14.06 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 32 | |
| 137 | EDAR/SNAP23 ratio | PRORT000978 | 13.82 | Protein ratios | Myeloid | 33 | 3 | 15 | 20 | |
| 138 | Food-related dermatitis | DERMA000011 | 13.81 | Dermatologic | Lymphocyte | 0 | 0 | 9 | 19 | |
| 139 | Medication, antispasmodic | GASTR000015 | 13.72 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 140 | EBAG9/FKBP5 ratio | PRORT000958 | 13.69 | Protein ratios | Lymphocyte | 1 | 5 | 8 | 24 | |
| 141 | PPP1R14D levels | PROLV001615 | 13.62 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 142 | Family history, asthma | IMMUN000047 | 13.61 | Immunologic | Lymphocyte | 5 | 3 | 17 | 26 | |
| 143 | CXCL16/NOTCH1 ratio | PRORT000822 | 13.61 | Protein ratios | Vascular | 15 | 3 | 15 | 44 | |
| 144 | GZMB levels | PROLV000948 | 13.55 | Protein levels | Lymphocyte | 108 | 3 | 14 | 28 | |
| 145 | TSC1 levels | PROLV002112 | 13.45 | Protein levels | Hepatocyte | 18 | 5 | 23 | 29 | |
| 146 | CD79B/TNFRSF4 ratio | PRORT000514 | 13.41 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 147 | ITGB1BP2/USP8 ratio | PRORT001390 | 13.37 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 148 | CALCOCO1/VPS53 ratio | PRORT000304 | 13.29 | Protein ratios | Epithelial | 0 | 2 | 13 | 39 | |
| 149 | CRTAM levels | PROLV000530 | 13.27 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 150 | CXCL9 levels | PROLV000587 | 13.26 | Protein levels | Lymphocyte | 72 | 2 | 13 | 32 | |
| 151 | VSTM2B levels | PROLV002175 | 13.23 | Protein levels | Lymphocyte | — | 3 | 16 | 34 | |
| 152 | CD27/NBL1 ratio | PRORT000415 | 13.12 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 153 | Mosaic chromosomal alteration | MISCL000014 | 13.07 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 154 | NECTIN2/NPDC1 ratio | PRORT001577 | 13.06 | Protein ratios | Vascular | 16 | 2 | 13 | 18 | |
| 155 | TP53BP1 levels | PROLV002090 | 13.02 | Protein levels | B / plasma cell | 66 | 2 | 10 | 28 | |
| 156 | GRAP2/SRC ratio | PRORT001246 | 13.01 | Protein ratios | Lymphocyte | 10 | 2 | 7 | 13 | |
| 157 | ERBB4/F3 ratio | PRORT001046 | 12.99 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 158 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 12.99 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 159 | GZMA/LTA ratio | PRORT001260 | 12.91 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 160 | PRG2 levels | PROLV001628 | 12.91 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 161 | Drug response, carboplatin | MALIG000047 | 12.89 | Malignancy | Lymphocyte | 0 | 1 | 9 | 27 | |
| 162 | CALCOCO1/PDLIM7 ratio | PRORT000300 | 12.89 | Protein ratios | Myeloid | 1 | 3 | 11 | 27 | |
| 163 | Pneumonia | IMMUN000069 | 12.81 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 164 | CD160 levels | PROLV000311 | 12.71 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 165 | CRTAM/GZMA ratio | PRORT000769 | 12.65 | Protein ratios | Lymphocyte | 34 | 3 | 14 | 33 | |
| 166 | DNAJC21 levels | PROLV000634 | 12.63 | Protein levels | Lymphocyte | 2 | 2 | 12 | 18 | |
| 167 | THBS2 levels | PROLV002026 | 12.56 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 168 | Cancer, Respiratory system | MALIG000027 | 12.49 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 169 | TXNL1 levels | PROLV002126 | 12.49 | Protein levels | Lymphocyte | 35 | 2 | 13 | 14 | |
| 170 | NME3 levels | PROLV001409 | 12.47 | Protein levels | Myeloid | 92 | 4 | 15 | 35 | |
| 171 | Cancer, Lung | MALIG000019 | 12.47 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 172 | UCMA levels | PROLV002135 | 12.47 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 173 | Bleeding gums | DENTA000011 | 12.47 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 174 | EDAR/TACC3 ratio | PRORT000980 | 12.43 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 175 | CC2D1A/STIP1 ratio | PRORT000329 | 12.43 | Protein ratios | Granulosa cell | 0 | 5 | 12 | 26 | |
| 176 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 12.43 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 177 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 12.35 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 178 | CD5/IL16 ratio | PRORT000467 | 12.35 | Protein ratios | Myeloid | 36 | 4 | 16 | 40 | |
| 179 | Physical activity, none | BEHAV000005 | 12.31 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 180 | Neoplasm, uncertain behaviour | MALIG000035 | 12.23 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 181 | CD27 levels | PROLV000324 | 12.20 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 182 | SLAMF8 levels | PROLV001877 | 12.19 | Protein levels | Myeloid | 34 | 5 | 12 | 28 | |
| 183 | Cutaneous fungal infection | IMMUN000058 | 12.16 | Immunologic | Myeloid | 28 | 1 | 9 | 13 | |
| 184 | IL10 levels | PROLV001042 | 12.11 | Protein levels | Lymphocyte | 50 | 1 | 13 | 25 | |
| 185 | SIGLEC1/SSC5D ratio | PRORT001786 | 12.02 | Protein ratios | Myeloid | 24 | 2 | 11 | 21 | |
| 186 | BCR/FOXO1 ratio | PRORT000224 | 12.01 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 187 | TNFRSF17 levels | PROLV002066 | 11.99 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 188 | Supplement use, glucosamine | DTSUP000025 | 11.95 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 189 | Iron content, Spleen | METBL000018 | 11.94 | Metabolic | Myeloid | 10 | 2 | 5 | 10 | |
| 190 | IL32 levels | PROLV001072 | 11.94 | Protein levels | Myeloid | 37 | 3 | 14 | 32 | |
| 191 | CDC27 levels | PROLV000367 | 11.80 | Protein levels | Lymphocyte | 4 | 3 | 9 | 24 | |
| 192 | B2M levels | PROLV000169 | 11.78 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 193 | CXCL5/PLXNA4 ratio | PRORT000829 | 11.74 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 194 | Obstetric trauma | REPRO000039 | 11.71 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 195 | Drug hypersensitivity | IMMUN000006 | 11.68 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 196 | Snoring | RESPI000036 | 11.62 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 197 | IBD-Inflammatory bowel disease | IMMUN000030 | 11.61 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 198 | SH3GLB2 levels | PROLV001854 | 11.61 | Protein levels | Lymphocyte | 14 | 3 | 17 | 52 | |
| 199 | CRTAM/PDCD1 ratio | PRORT000773 | 11.48 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 200 | LGALS3BP levels | PROLV001203 | 11.44 | Protein levels | Myeloid | 120 | 3 | 12 | 16 | |
| 201 | Female genital dysplasia | REPRO000007 | 11.40 | Reproductive | Hepatocyte | 17 | 2 | 8 | 22 | |
| 202 | APP/HBEGF ratio | PRORT000126 | 11.28 | Protein ratios | Myeloid | 46 | 5 | 17 | 26 | |
| 203 | MAVS/MED18 ratio | PRORT001495 | 11.26 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 204 | F5 levels | PROLV000747 | 11.20 | Protein levels | Muscle / cardiac | 0 | 3 | 14 | 28 | |
| 205 | MED18/TBL1X ratio | PRORT001511 | 11.12 | Protein ratios | Myeloid | 35 | 3 | 11 | 22 | |
| 206 | Heme malignancy, Lymphoma | MALIG000044 | 11.12 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 207 | TNFRSF9 levels | PROLV002074 | 11.04 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 208 | SUMF1 levels | PROLV001975 | 10.99 | Protein levels | Lymphocyte | 0 | 4 | 12 | 28 | |
| 209 | CRACR2A/LBR ratio | PRORT000741 | 10.98 | Protein ratios | Myeloid | 0 | 3 | 17 | 17 | |
| 210 | CD48/FCRL6 ratio | PRORT000464 | 10.94 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 211 | Handedness | BEHAV000003 | 10.93 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 212 | Dizziness and giddiness | AUDIO000020 | 10.87 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 213 | TRAF2/WWP2 ratio | PRORT001857 | 10.76 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 51 | |
| 214 | IFNG levels | PROLV001019 | 10.76 | Protein levels | Lymphocyte | 30 | 3 | 11 | 38 | |
| 215 | HMBS/PKLR ratio | PRORT001288 | 10.72 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 216 | Middle ear and mastoid disorder | AUDIO000016 | 10.70 | Auditory | B / plasma cell | 51 | 4 | 14 | 30 | |
| 217 | Medication, dermatologic | DERMA000024 | 10.68 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 218 | UGDH levels | PROLV002138 | 10.67 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 219 | ITGB1BP2/TIA1 ratio | PRORT001389 | 10.66 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 220 | GZMH/KLRD1 ratio | PRORT001264 | 10.63 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 221 | CXCL16 levels | PROLV000581 | 10.63 | Protein levels | Lymphocyte | 67 | 3 | 13 | 36 | |
| 222 | Asthma | IMMUN000005 | 10.62 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 223 | AHSP/BLVRB ratio | PRORT000056 | 10.45 | Protein ratios | Stromal / connective | 33 | 2 | 13 | 32 | |
| 224 | Sarcoidosis | IMMUN000080 | 10.39 | Immunologic | Lymphocyte | 82 | 3 | 15 | 37 | |
| 225 | BAG6/BMP6 ratio | PRORT000200 | 10.32 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 38 | |
| 226 | Mouth ulcers | DENTA000010 | 10.29 | Dental | Myeloid | 194 | 4 | 15 | 36 | |
| 227 | Tyrosine metabolites | METAB000016 | 10.21 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 228 | Cancer, Pancreas | MALIG000025 | 10.18 | Malignancy | Myeloid | 0 | 0 | 5 | 4 | |
| 229 | IL1RL1 levels | PROLV001063 | 10.17 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 230 | FCRL2/SEMA7A ratio | PRORT001131 | 10.11 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 231 | Chronic illness or disability | MISCL000004 | 10.09 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 232 | Medication use | MISCL000037 | 10.08 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 233 | CD27/TGFBR2 ratio | PRORT000417 | 10.08 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 234 | EDAR/IPCEF1 ratio | PRORT000970 | 10.05 | Protein ratios | Myeloid | 32 | 3 | 15 | 18 | |
| 235 | CSNK1D levels | PROLV000542 | 10.00 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 236 | DBNL/EDAR ratio | PRORT000865 | 9.97 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 237 | SRP14 levels | PROLV001943 | 9.95 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 238 | CALCOCO1/METAP2 ratio | PRORT000299 | 9.88 | Protein ratios | Muscle / cardiac | 0 | 5 | 16 | 28 | |
| 239 | Amino acid metabolism disorder | METBL000001 | 9.85 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 240 | IFI30 levels | PROLV001014 | 9.83 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 241 | RBFOX3 levels | PROLV001708 | 9.81 | Protein levels | Lymphocyte | 0 | 2 | 16 | 35 | |
| 242 | Erythrocyte | HEMAT000005 | 9.79 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 243 | BCR/ITGB1BP2 ratio | PRORT000227 | 9.74 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 244 | Allergic rhinitis | IMMUN000004 | 9.73 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 245 | Age at onset of walking | NEURO000023 | 9.68 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 246 | BLNK levels | PROLV000200 | 9.66 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 247 | KLK8/WFDC12 ratio | PRORT001413 | 9.56 | Protein ratios | Cutaneous epithelium | 7 | 1 | 13 | 21 | |
| 248 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 9.55 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 249 | RAP1A levels | PROLV001704 | 9.53 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 250 | CD74/NPDC1 ratio | PRORT000506 | 9.45 | Protein ratios | Lymphocyte | 43 | 3 | 22 | 25 | |
| 251 | Wisdom tooth surgery | DENTA000005 | 9.36 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 252 | STX6 levels | PROLV001969 | 9.35 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 253 | Noninfective gastroenteritis and colitis | GASTR000013 | 9.34 | Gastrointestinal | Myeloid | 78 | 2 | 14 | 27 | |
| 254 | IGFBP6/MFAP5 ratio | PRORT001336 | 9.33 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 255 | Family history, lung cancer | MALIG000039 | 9.29 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 256 | Ocular refraction | OPHTH000033 | 9.27 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 257 | Erythematosquamous dermatosis | DERMA000009 | 9.26 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 258 | FCRL5/ICAM3 ratio | PRORT001133 | 9.22 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 259 | CA1/HMBS ratio | PRORT000269 | 9.22 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 260 | MAPRE3 levels | PROLV001273 | 9.15 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 261 | ITGB1BP2/WASF1 ratio | PRORT001391 | 9.06 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 262 | TFRC levels | PROLV002017 | 9.04 | Protein levels | Myeloid | 70 | 3 | 7 | 24 | |
| 263 | UNC5D levels | PROLV002141 | 9.04 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 264 | INSL5 levels | PROLV001093 | 9.01 | Protein levels | Hematopoietic progenitor | 10 | 1 | 5 | 7 | |
| 265 | CD27/TNFRSF9 ratio | PRORT000419 | 8.96 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 266 | HBEGF/PDGFA ratio | PRORT001268 | 8.92 | Protein ratios | Myeloid | 63 | 2 | 9 | 13 | |
| 267 | RHOC/TBCB ratio | PRORT001740 | 8.89 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 268 | ADAM12 levels | PROLV000025 | 8.89 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 269 | ITGB7 levels | PROLV001116 | 8.84 | Protein levels | Hepatocyte | 157 | 4 | 17 | 37 | |
| 270 | MINPP1 levels | PROLV001317 | 8.81 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 271 | TNFRSF13B levels | PROLV002063 | 8.79 | Protein levels | B / plasma cell | 55 | 2 | 8 | 14 | |
| 272 | CD7 levels | PROLV000352 | 8.69 | Protein levels | Lymphocyte | 67 | 3 | 12 | 36 | |
| 273 | TNF/TNFRSF1B ratio | PRORT001844 | 8.66 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 274 | BMP7 levels | PROLV000205 | 8.59 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 275 | SNAP23/TBL1X ratio | PRORT001794 | 8.56 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 276 | GALNT10/SEMA7A ratio | PRORT001202 | 8.53 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 277 | FAM3B/FUT3_FUT5 ratio | PRORT001112 | 8.40 | Protein ratios | Hepatocyte | 18 | 2 | 10 | 19 | |
| 278 | INPP5J levels | PROLV001090 | 8.35 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 279 | Medication, chronic lung disease | RESPI000006 | 8.31 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 280 | CASP10 levels | PROLV000266 | 8.30 | Protein levels | Lymphocyte | 3 | 4 | 11 | 33 | |
| 281 | Intracranial volume | NIMAG000025 | 8.29 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 282 | FCRL1/TCL1A ratio | PRORT001126 | 8.24 | Protein ratios | B / plasma cell | 21 | 3 | 14 | 38 | |
| 283 | Choroid plexus volume | NIMAG000020 | 8.23 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 284 | Citrulline | METAB000020 | 8.21 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 285 | EDAR/F2R ratio | PRORT000969 | 8.20 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 286 | Bleeding | HEMAT000016 | 8.15 | Hematologic | B / plasma cell | 9 | 1 | 4 | 17 | |
| 287 | Pain, widespread | MSKEL000042 | 8.14 | Musculoskeletal | Lymphocyte | 0 | 2 | 16 | 37 | |
| 288 | Seborrhoeic dermatitis | DERMA000020 | 8.13 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 289 | FCRL6/GZMA ratio | PRORT001137 | 8.11 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 290 | COX5B/GFER ratio | PRORT000716 | 8.09 | Protein ratios | Lymphocyte | 1 | 1 | 12 | 33 | |
| 291 | FCER1A levels | PROLV000776 | 8.07 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 292 | CAPS levels | PROLV000264 | 8.07 | Protein levels | Hematopoietic progenitor | 43 | 2 | 5 | 11 | |
| 293 | OSMR levels | PROLV001476 | 8.07 | Protein levels | Lymphocyte | 78 | 3 | 14 | 34 | |
| 294 | LTA4H levels | PROLV001240 | 8.03 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 295 | IL22 levels | PROLV001066 | 8.01 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 296 | Low hand grip strength | MSKEL000032 | 7.97 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 297 | CA1/CA3 ratio | PRORT000268 | 7.96 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 298 | Exotropia | OPHTH000022 | 7.95 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 299 | PDCD1/TNFRSF9 ratio | PRORT001631 | 7.87 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 300 | LMNB2 levels | PROLV001218 | 7.86 | Protein levels | Myeloid | 6 | 1 | 14 | 18 | |
| 301 | BIN2/FYB1 ratio | PRORT000232 | 7.85 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 302 | IL15/KLRD1 ratio | PRORT001343 | 7.81 | Protein ratios | Myeloid | 41 | 4 | 12 | 23 | |
| 303 | EDAR/ITGB1BP2 ratio | PRORT000972 | 7.81 | Protein ratios | Myeloid | 49 | 5 | 17 | 20 | |
| 304 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 7.81 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 305 | NCR1 levels | PROLV001382 | 7.77 | Protein levels | Lymphocyte | 117 | 2 | 14 | 32 | |
| 306 | TCL1A/TNFRSF13C ratio | PRORT001829 | 7.77 | Protein ratios | B / plasma cell | 23 | 2 | 14 | 31 | |
| 307 | KDM3A levels | PROLV001132 | 7.74 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 308 | Malocclusion | DENTA000008 | 7.71 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 309 | Erythematous skin disorder | DERMA000010 | 7.71 | Dermatologic | Lymphocyte | 18 | 2 | 19 | 22 | |
| 310 | PCOLCE levels | PROLV001510 | 7.68 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 311 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 7.68 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 312 | EBAG9/TGFB1 ratio | PRORT000963 | 7.67 | Protein ratios | Myeloid | 11 | 4 | 18 | 48 | |
| 313 | Disability allowance, none | SOCIO000016 | 7.67 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 314 | Chronic respiratory disease | RESPI000003 | 7.64 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 315 | Household size | SOCIO000011 | 7.62 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 316 | MAP3K5/ZBTB16 ratio | PRORT001489 | 7.60 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 317 | ADH4/SCLY ratio | PRORT000043 | 7.60 | Protein ratios | Hepatocyte | 18 | 4 | 15 | 30 | |
| 318 | CD27/DLL1 ratio | PRORT000412 | 7.49 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 319 | CD101 levels | PROLV000308 | 7.47 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 320 | LBR/POLR2F ratio | PRORT001439 | 7.46 | Protein ratios | Lymphocyte | 5 | 4 | 8 | 36 | |
| 321 | CHMP1A/RHOC ratio | PRORT000613 | 7.43 | Protein ratios | Myeloid | 18 | 3 | 13 | 19 | |
| 322 | PFKM levels | PROLV001541 | 7.43 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 323 | KYNU/SCLY ratio | PRORT001416 | 7.39 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 324 | NPPB levels | PROLV001424 | 7.37 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 325 | PDCD1/TNFRSF4 ratio | PRORT001629 | 7.35 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 326 | Housing type | SOCIO000013 | 7.33 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 327 | Medication, analgesic or antidepressant | MISCL000033 | 7.31 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 328 | AXL/IL18BP ratio | PRORT000180 | 7.25 | Protein ratios | Neural / glial | 26 | 2 | 10 | 15 | |
| 329 | MAP3K5/MAVS ratio | PRORT001488 | 7.21 | Protein ratios | B / plasma cell | 7 | 3 | 12 | 15 | |
| 330 | CCN2/HBEGF ratio | PRORT000365 | 7.08 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 331 | CRADD/HSPA1A ratio | PRORT000747 | 7.06 | Protein ratios | Neural / glial | 20 | 3 | 6 | 17 | |
| 332 | Educational attainment, none | SOCIO000001 | 7.05 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 333 | EFNA4/TNFRSF9 ratio | PRORT000992 | 7.03 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 334 | Upper respiratory tract disease | RESPI000042 | 7.01 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 335 | HBEGF/PLXNA4 ratio | PRORT001270 | 6.98 | Protein ratios | Myeloid | 60 | 4 | 14 | 23 | |
| 336 | Non-cancer illness history | MISCL000030 | 6.96 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 337 | FAM13A levels | PROLV000759 | 6.95 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 338 | CEP43/MPHOSPH8 ratio | PRORT000599 | 6.93 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 339 | IGSF8/NECTIN2 ratio | PRORT001339 | 6.90 | Protein ratios | Granulosa cell | 15 | 1 | 14 | 37 | |
| 340 | Sjogren syndrome | IMMUN000043 | 6.88 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 341 | ENO2/RWDD1 ratio | PRORT001029 | 6.87 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 342 | SMPD3 levels | PROLV001902 | 6.87 | Protein levels | Lymphocyte | 11 | 2 | 13 | 22 | |
| 343 | SDC4/WWP2 ratio | PRORT001769 | 6.85 | Protein ratios | Myeloid | 11 | 3 | 10 | 19 | |
| 344 | BCL2 levels | PROLV000185 | 6.84 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 345 | CD79B/FCRL1 ratio | PRORT000510 | 6.81 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 346 | MCTS1 levels | PROLV001287 | 6.81 | Protein levels | Myeloid | 59 | 3 | 10 | 14 | |
| 347 | NRSN1 levels | PROLV001436 | 6.80 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 348 | CALCOCO1/CASP3 ratio | PRORT000291 | 6.78 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 349 | Ceramides | LIPID000065 | 6.75 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 350 | Operation, respiratory | RESPI000025 | 6.74 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 351 | External ear disorder | AUDIO000001 | 6.74 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 352 | Gut microbial abundance, Rhodanobacter | GASTR000033 | 6.72 | Gastrointestinal | Hepatocyte | 0 | 2 | 18 | 46 | |
| 353 | Wheeze | RESPI000034 | 6.68 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 354 | ARHGAP25/RNF41 ratio | PRORT000139 | 6.66 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 355 | Medication, immunosuppressive | IMMUN000084 | 6.65 | Immunologic | B / plasma cell | 59 | 3 | 8 | 13 | |
| 356 | Organic acids | METAB000068 | 6.65 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 357 | CA3/HMBS ratio | PRORT000280 | 6.60 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 358 | STX8 levels | PROLV001970 | 6.60 | Protein levels | Myeloid | 0 | 3 | 5 | 14 | |
| 359 | GZMA/TNFRSF8 ratio | PRORT001262 | 6.56 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 360 | CDSN/LY6D ratio | PRORT000583 | 6.55 | Protein ratios | Cutaneous epithelium | 33 | 2 | 18 | 32 | |
| 361 | Temporomandibular joint disorder | MSKEL000022 | 6.53 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 362 | GDF15 levels | PROLV000869 | 6.51 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 363 | Latent factor, red cell | HEMAT000038 | 6.50 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 364 | EZR levels | PROLV000739 | 6.49 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 365 | CXCL5/MESD ratio | PRORT000828 | 6.49 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 366 | GBP4 levels | PROLV000862 | 6.47 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 367 | Neoplasm, Skin | MALIG000034 | 6.46 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 368 | GPLD1 levels | PROLV000926 | 6.40 | Protein levels | Lymphocyte | 0 | 1 | 4 | 8 | |
| 369 | Tooth agenesis | DENTA000003 | 6.39 | Dental | Epithelial | 0 | 0 | 7 | 14 | |
| 370 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 6.37 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 371 | ATXN10/CASP10 ratio | PRORT000161 | 6.37 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 372 | Hypothyroidism, secondary | ENDOC000015 | 6.35 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 373 | CD22/TCL1A ratio | PRORT000404 | 6.34 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 374 | Chest pain | CARDI000052 | 6.34 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 375 | CA2/CA3 ratio | PRORT000274 | 6.32 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 376 | SEMA4C levels | PROLV001809 | 6.32 | Protein levels | Hepatocyte | 20 | 4 | 17 | 38 | |
| 377 | SPESP1 levels | PROLV001926 | 6.31 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 378 | LRRC37A2 levels | PROLV001233 | 6.31 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 379 | Atrophic skin disorder | DERMA000037 | 6.31 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 380 | ENO2/PLXNA4 ratio | PRORT001027 | 6.30 | Protein ratios | Myeloid | 5 | 4 | 13 | 39 | |
| 381 | Grain and bakery preference | DTSUP000013 | 6.26 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 382 | CCL8 levels | PROLV000300 | 6.26 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 383 | SIRT1 levels | PROLV001869 | 6.23 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 384 | CRTAM/KLRD1 ratio | PRORT000771 | 6.22 | Protein ratios | Lymphocyte | 59 | 3 | 13 | 33 | |
| 385 | Respiratory insufficiency | RESPI000031 | 6.19 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 386 | FCRL2/TNFRSF13B ratio | PRORT001132 | 6.18 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 387 | CD27/TNFRSF13B ratio | PRORT000418 | 6.17 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 388 | CASP8/DDX58 ratio | PRORT000321 | 6.17 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 389 | EBAG9/EDAR ratio | PRORT000957 | 6.14 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 390 | EDAR/YES1 ratio | PRORT000985 | 6.12 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 391 | HAVCR2 levels | PROLV000954 | 6.11 | Protein levels | Myeloid | 31 | 0 | 3 | 11 | |
| 392 | CWC15 levels | PROLV000572 | 6.09 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 393 | PALM2 levels | PROLV001490 | 6.09 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 394 | QPCT/RNASET2 ratio | PRORT001726 | 6.08 | Protein ratios | B / plasma cell | 68 | 5 | 12 | 31 | |
| 395 | Smoking dependency | PSYCH000047 | 6.06 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 396 | CD160/NCR1 ratio | PRORT000378 | 6.03 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 397 | LAYN/TNFRSF4 ratio | PRORT001434 | 6.02 | Protein ratios | Myeloid | 8 | 3 | 7 | 11 | |
| 398 | TNFRSF4 levels | PROLV002071 | 6.00 | Protein levels | Lymphocyte | 72 | 1 | 8 | 16 | |
| 399 | Cancer, Cervix | MALIG000012 | 5.98 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 400 | FGFR4 levels | PROLV000802 | 5.98 | Protein levels | Hepatocyte | 102 | 2 | 8 | 24 | |
| 401 | CALCOCO1/IRAG2 ratio | PRORT000297 | 5.95 | Protein ratios | Neural / glial | 0 | 2 | 18 | 34 | |
| 402 | PEAR1/PECAM1 ratio | PRORT001657 | 5.94 | Protein ratios | Myeloid | 24 | 3 | 15 | 24 | |
| 403 | Anterior eye disorder | OPHTH000001 | 5.94 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 404 | Primary sclerosing cholangitis, PSC | IMMUN000018 | 5.94 | Immunologic | B / plasma cell | 90 | 3 | 12 | 15 | |
| 405 | LPCAT2/SERPINB8 ratio | PRORT001459 | 5.92 | Protein ratios | Myeloid | 19 | 4 | 11 | 23 | |
| 406 | GZMA/TNFRSF4 ratio | PRORT001261 | 5.91 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 407 | ARG1 levels | PROLV000134 | 5.91 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 408 | FCRL6/KLRD1 ratio | PRORT001138 | 5.91 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 409 | CEP43 levels | PROLV000402 | 5.90 | Protein levels | Myeloid | 8 | 4 | 9 | 17 | |
| 410 | Medication, antipyretic | MISCL000035 | 5.88 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 411 | CALCOCO1/IKBKG ratio | PRORT000295 | 5.85 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 412 | Sinusitis | RESPI000039 | 5.83 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 413 | Vitamin C | METAB000077 | 5.83 | Metabolites | Lymphocyte | 4 | 2 | 10 | 33 | |
| 414 | PROK1 levels | PROLV001638 | 5.82 | Protein levels | Myeloid | 74 | 2 | 15 | 17 | |
| 415 | ATF6 levels | PROLV000157 | 5.80 | Protein levels | Myeloid | 5 | 4 | 11 | 19 | |
| 416 | PBLD levels | PROLV001500 | 5.80 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 417 | TNF levels | PROLV002053 | 5.77 | Protein levels | Lymphocyte | 30 | 2 | 10 | 20 | |
| 418 | EDAR/SERPINB1 ratio | PRORT000977 | 5.77 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 419 | XCL1 levels | PROLV002196 | 5.76 | Protein levels | Myeloid | 70 | 2 | 9 | 18 | |
| 420 | PAXX levels | PROLV001499 | 5.74 | Protein levels | Lymphocyte | 14 | 4 | 15 | 31 | |
| 421 | Estradiol | ENDOC000006 | 5.72 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 422 | Conjunctivitis | OPHTH000002 | 5.72 | Ophthalmic | Lymphocyte | 26 | 3 | 10 | 30 | |
| 423 | CASP1 levels | PROLV000265 | 5.69 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 424 | AHCY/HSPA1A ratio | PRORT000055 | 5.66 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 425 | CDKN2D/ITGB1BP2 ratio | PRORT000578 | 5.65 | Protein ratios | Hematopoietic progenitor | 17 | 5 | 12 | 35 | |
| 426 | Parkinson disease | NEURO000022 | 5.64 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 427 | DNMBP/WWP2 ratio | PRORT000934 | 5.63 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 428 | TNFSF13B levels | PROLV002079 | 5.63 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 429 | CXCL11/DKK1 ratio | PRORT000817 | 5.61 | Protein ratios | Myeloid | 13 | 4 | 15 | 21 | |
| 430 | Shift work | SOCIO000008 | 5.61 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 431 | MICB or MICA levels | PROLV001312 | 5.60 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 432 | SRC/TBL1X ratio | PRORT001814 | 5.60 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 433 | CLEC1B/HBEGF ratio | PRORT000638 | 5.59 | Protein ratios | Myeloid | 60 | 2 | 15 | 15 | |
| 434 | CCL19 levels | PROLV000285 | 5.57 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 435 | Smoking effects on COPD | RESPI000012 | 5.57 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 436 | GNLY/GZMA ratio | PRORT001221 | 5.55 | Protein ratios | Lymphocyte | 41 | 3 | 18 | 47 | |
| 437 | Benign neoplasm, Uterus | MALIG000008 | 5.54 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 438 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 5.47 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 439 | CHIT1 levels | PROLV000429 | 5.46 | Protein levels | Myeloid | 45 | 3 | 9 | 16 | |
| 440 | SNRPB2 levels | PROLV001910 | 5.46 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 441 | FCAMR levels | PROLV000774 | 5.44 | Protein levels | Hepatocyte | 81 | 2 | 8 | 20 | |
| 442 | Brain general volume | NIMAG000015 | 5.39 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 443 | CRACR2A/IRAG2 ratio | PRORT000740 | 5.37 | Protein ratios | Hepatocyte | 1 | 3 | 11 | 37 | |
| 444 | FOXO1/USP8 ratio | PRORT001177 | 5.37 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 445 | GSTA1/PBLD ratio | PRORT001250 | 5.36 | Protein ratios | Hepatocyte | 65 | 3 | 13 | 30 | |
| 446 | NMNAT1 levels | PROLV001411 | 5.33 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 447 | GFRA2/IL12A_IL12B ratio | PRORT001210 | 5.33 | Protein ratios | B / plasma cell | 52 | 3 | 12 | 22 | |
| 448 | MICB_MICA/TEK ratio | PRORT001533 | 5.31 | Protein ratios | Myeloid | 65 | 3 | 12 | 25 | |
| 449 | ICAM5 levels | PROLV001008 | 5.31 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 450 | PSIP1 levels | PROLV001657 | 5.30 | Protein levels | Muscle / cardiac | 10 | 2 | 10 | 35 | |
| 451 | CSF2RB levels | PROLV000539 | 5.30 | Protein levels | Lymphocyte | 10 | 2 | 6 | 24 | |
| 452 | MZB1/TNFRSF13B ratio | PRORT001568 | 5.30 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 453 | ACVRL1/TNFRSF9 ratio | PRORT000018 | 5.30 | Protein ratios | Myeloid | 12 | 2 | 11 | 19 | |
| 454 | Cancer, Thyroid | MALIG000032 | 5.30 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 455 | DBNL/HSPA1A ratio | PRORT000867 | 5.30 | Protein ratios | Muscle / cardiac | 3 | 2 | 11 | 18 | |
| 456 | OCLN levels | PROLV001461 | 5.29 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 457 | FCRL5/TNFRSF13B ratio | PRORT001136 | 5.28 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 458 | EBAG9/TBCC ratio | PRORT000962 | 5.27 | Protein ratios | Muscle / cardiac | 5 | 3 | 16 | 46 | |
| 459 | Circulatory disorder | VASCU000025 | 5.26 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 460 | Bipolar disorder | PSYCH000023 | 5.26 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 461 | JCHAIN levels | PROLV001126 | 5.25 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 462 | Reticulocyte | HEMAT000013 | 5.24 | Hematologic | Platelet | 1,657 | 4 | 2 | 9 | |
| 463 | DBI/EDAR ratio | PRORT000861 | 5.23 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 464 | NMT1 levels | PROLV001412 | 5.21 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 465 | PPM1B levels | PROLV001610 | 5.20 | Protein levels | Lymphocyte | 11 | 2 | 12 | 22 | |
| 466 | IL19 levels | PROLV001058 | 5.19 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 467 | Hypothyroidism, acquired | ENDOC000012 | 5.18 | Endocrine | Hepatocyte | 1 | 4 | 11 | 37 | |
| 468 | PLXNB3/SNAP23 ratio | PRORT001691 | 5.18 | Protein ratios | Myeloid | 0 | 5 | 13 | 36 | |
| 469 | BLVRB/CA3 ratio | PRORT000240 | 5.17 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 470 | Miscarriage | REPRO000038 | 5.17 | Reproductive | Lymphocyte | 0 | 2 | 15 | 31 | |
| 471 | ITGB1BP2/MITD1 ratio | PRORT001385 | 5.17 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 472 | Spine surgery | MSKEL000051 | 5.15 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 473 | PDLIM7/PLA2G4A ratio | PRORT001654 | 5.15 | Protein ratios | Platelet | 8 | 4 | 5 | 18 | |
| 474 | Amino sugar metabolites | METAB000034 | 5.14 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 475 | FLT3/FLT3LG ratio | PRORT001165 | 5.13 | Protein ratios | Lymphocyte | 5 | 5 | 11 | 30 | |
| 476 | NOTCH1/SEMA7A ratio | PRORT001591 | 5.12 | Protein ratios | B / plasma cell | 20 | 2 | 11 | 15 | |
| 477 | Occupational attainment | SOCIO000007 | 5.08 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 478 | CNTNAP4 levels | PROLV000481 | 5.07 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 479 | IL16 levels | PROLV001050 | 5.07 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 480 | APBB1IP/POLR2F ratio | PRORT000115 | 5.06 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 481 | Female genital tract polyp | REPRO000009 | 5.06 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 482 | LTA/LTBR ratio | PRORT001463 | 5.04 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 483 | ICAM3/LY9 ratio | PRORT001326 | 5.03 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 484 | CXCL11/ITGB1BP2 ratio | PRORT000818 | 5.02 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 15 | |
| 485 | Pulmonary fibrosis | RESPI000017 | 5.02 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 486 | Latent factor, white cell | HEMAT000039 | 5.00 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 487 | FUT3 or FUT5 levels | PROLV000838 | 4.97 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 488 | EDAR/EGF ratio | PRORT000965 | 4.96 | Protein ratios | Lymphocyte | 3 | 4 | 12 | 35 | |
| 489 | Gut microbial abundance, Staphylococcus | GASTR000036 | 4.92 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 490 | DAB2/ERBIN ratio | PRORT000835 | 4.92 | Protein ratios | Muscle / cardiac | 0 | 5 | 15 | 36 | |
| 491 | AMOTL2 levels | PROLV000088 | 4.92 | Protein levels | Lymphocyte | 1 | 0 | 9 | 14 | |
| 492 | GCHFR levels | PROLV000867 | 4.91 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 493 | Allergic conjunctivitis | IMMUN000002 | 4.91 | Immunologic | Lymphocyte | 34 | 2 | 8 | 28 | |
| 494 | Nerve root disorder | NEURO000030 | 4.90 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 495 | Cancer, Skin | MALIG000028 | 4.90 | Malignancy | Lymphocyte | 302 | 3 | 14 | 19 | |
| 496 | CDH17/SPINT1 ratio | PRORT000551 | 4.90 | Protein ratios | Lymphocyte | 11 | 1 | 12 | 15 | |
| 497 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 4.86 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 498 | C21orf58 levels | PROLV000231 | 4.84 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 499 | DAG1/F2R ratio | PRORT000846 | 4.83 | Protein ratios | Myeloid | 18 | 3 | 8 | 18 | |
| 500 | White blood cell disorder | HEMAT000019 | 4.80 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 501 | EIF4G1/FKBP5 ratio | PRORT001008 | 4.79 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 502 | CC2D1A/CRADD ratio | PRORT000327 | 4.77 | Protein ratios | Myeloid | 1 | 3 | 7 | 21 | |
| 503 | S100A11/S100A12 ratio | PRORT001753 | 4.77 | Protein ratios | B / plasma cell | 25 | 4 | 17 | 38 | |
| 504 | SMNDC1 levels | PROLV001898 | 4.76 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 505 | CD27/NECTIN4 ratio | PRORT000416 | 4.76 | Protein ratios | Lymphocyte | 15 | 2 | 13 | 34 | |
| 506 | Medication, hypnotic or sedative | PSYCH000020 | 4.75 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 507 | IBD-Ulcerative colitis | IMMUN000031 | 4.75 | Immunologic | Myeloid | 239 | 2 | 12 | 28 | |
| 508 | AHNAK levels | PROLV000062 | 4.75 | Protein levels | Lymphocyte | 17 | 2 | 12 | 33 | |
| 509 | MAP3K5 levels | PROLV001268 | 4.72 | Protein levels | Vascular | 0 | 1 | 4 | 12 | |
| 510 | SPTLC1 levels | PROLV001941 | 4.68 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 511 | CXCL10 levels | PROLV000576 | 4.65 | Protein levels | Myeloid | 89 | 2 | 9 | 19 | |
| 512 | Cancer, Bladder | MALIG000009 | 4.65 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 513 | Lifespan | AGING000006 | 4.65 | Aging | Neural / glial | 2 | 1 | 9 | 10 | |
| 514 | ARHGAP30 levels | PROLV000137 | 4.63 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 515 | Vaccination adverse effects | IMMUN000008 | 4.63 | Immunologic | Muscle / cardiac | 0 | 3 | 7 | 37 | |
| 516 | EDAR/F11R ratio | PRORT000968 | 4.59 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 517 | FCRL5 levels | PROLV000786 | 4.58 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 518 | Gut microbial abundance, Rubneribacter | GASTR000035 | 4.58 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 519 | AIF1 levels | PROLV000068 | 4.58 | Protein levels | Myeloid | 36 | 3 | 9 | 13 | |
| 520 | FCRL1/TNFRSF13C ratio | PRORT001127 | 4.57 | Protein ratios | B / plasma cell | 39 | 3 | 7 | 10 | |
| 521 | EGLN1 levels | PROLV000688 | 4.57 | Protein levels | Lymphocyte | 10 | 5 | 9 | 39 | |
| 522 | JAM2/TNFRSF14 ratio | PRORT001399 | 4.56 | Protein ratios | Platelet | 2 | 6 | 12 | 25 | |
| 523 | MPHOSPH8/USP8 ratio | PRORT001555 | 4.56 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 524 | CRTAP levels | PROLV000531 | 4.56 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 525 | NFATC3 levels | PROLV001396 | 4.52 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 526 | PTPRC levels | PROLV001674 | 4.50 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 527 | Ataxia | NEURO000013 | 4.49 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 528 | DOK2/GRAP2 ratio | PRORT000938 | 4.49 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 529 | Cancer, Melanoma | MALIG000020 | 4.48 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 530 | Spleen volume | HEMAT000042 | 4.46 | Hematologic | B / plasma cell | 17 | 4 | 8 | 13 | |
| 531 | ARHGEF12/IRAK4 ratio | PRORT000141 | 4.46 | Protein ratios | Stromal / connective | 0 | 4 | 9 | 23 | |
| 532 | Electrolyte disorder | METBL000004 | 4.45 | Metabolic | Hepatocyte | 5 | 0 | 5 | 10 | |
| 533 | Cough | RESPI000027 | 4.42 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 534 | APRT levels | PROLV000131 | 4.40 | Protein levels | Lymphocyte | 4 | 3 | 7 | 36 | |
| 535 | Medication, musculoskeletal | MSKEL000026 | 4.39 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 5 | |
| 536 | FCRL2/LY9 ratio | PRORT001130 | 4.39 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 537 | Respiratory infection | IMMUN000070 | 4.38 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 538 | KLRK1 levels | PROLV001164 | 4.36 | Protein levels | Lymphocyte | 90 | 2 | 14 | 31 | |
| 539 | Heme malignancy, Leukaemia | MALIG000042 | 4.35 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 540 | CLIC5 levels | PROLV000458 | 4.33 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 541 | BTN3A2 levels | PROLV000220 | 4.32 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 542 | ENO2/HCLS1 ratio | PRORT001023 | 4.29 | Protein ratios | Myeloid | 13 | 2 | 11 | 16 | |
| 543 | IL5RA levels | PROLV001076 | 4.28 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 544 | Social and economic stability | SOCIO000028 | 4.26 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 545 | MED18/SMAD1 ratio | PRORT001509 | 4.25 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 546 | Dietary restriction | DTSUP000009 | 4.23 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 547 | FUT8/VEGFC ratio | PRORT001193 | 4.23 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 548 | Psoriatic arthritis vs psoriasis | IMMUN000041 | 4.21 | Immunologic | Neural / glial | 7 | 3 | 10 | 12 | |
| 549 | Raynaud phenomenon | VASCU000060 | 4.19 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 550 | CFHR5 levels | PROLV000417 | 4.19 | Protein levels | Hepatocyte | 18 | 3 | 9 | 16 | |
| 551 | LCN2/PGLYRP1 ratio | PRORT001441 | 4.18 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 552 | Free thyroxine | ENDOC000018 | 4.18 | Endocrine | Hepatocyte | 8 | 3 | 9 | 12 | |
| 553 | Histidine metabolites | METAB000008 | 4.13 | Metabolites | Granulosa cell | 3 | 0 | 3 | 9 | |
| 554 | ATP5IF1/FXN ratio | PRORT000157 | 4.11 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 555 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 4.09 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 556 | Glutamate metabolites | METAB000005 | 4.09 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 557 | Connective tissue disorder | MSKEL000060 | 4.09 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 558 | DLG4 levels | PROLV000624 | 4.06 | Protein levels | Lymphocyte | 5 | 1 | 5 | 33 | |
| 559 | Ankylosing spondylitis | IMMUN000022 | 4.04 | Immunologic | Lymphocyte | 83 | 4 | 8 | 19 | |
| 560 | Fatty acids, undecenoic acid | LIPID000030 | 4.03 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 561 | ING1 levels | PROLV001086 | 4.02 | Protein levels | Vascular | 0 | 3 | 8 | 26 | |
| 562 | EDAR/IRAK4 ratio | PRORT000971 | 4.00 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 563 | CHI3L1/PRSS8 ratio | PRORT000611 | 3.99 | Protein ratios | Myeloid | 7 | 5 | 11 | 23 | |
| 564 | Plasma protein metabolism disorder | METBL000029 | 3.98 | Metabolic | Hepatocyte | 26 | 2 | 6 | 24 | |
| 565 | HEXIM1/TRIAP1 ratio | PRORT001281 | 3.97 | Protein ratios | Myeloid | 2 | 3 | 17 | 30 | |
| 566 | Glomerular disease | NEPHR000006 | 3.96 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 567 | CALCOCO1/PFKFB2 ratio | PRORT000301 | 3.96 | Protein ratios | Myeloid | 1 | 5 | 10 | 23 | |
| 568 | CD27/FCRL5 ratio | PRORT000413 | 3.95 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 569 | CNTNAP2/DPP6 ratio | PRORT000690 | 3.94 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 570 | PARP1 levels | PROLV001497 | 3.94 | Protein levels | Lymphocyte | 2 | 6 | 14 | 35 | |
| 571 | Retinal vascular disorder | OPHTH000044 | 3.93 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 572 | CD69/NFATC1 ratio | PRORT000493 | 3.93 | Protein ratios | Myeloid | 0 | 2 | 13 | 37 | |
| 573 | F8 levels | PROLV000749 | 3.92 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 574 | Arthropathy, enteropathic | IMMUN000009 | 3.91 | Immunologic | Lymphocyte | 10 | 0 | 3 | 15 | |
| 575 | IGLC2 levels | PROLV001035 | 3.91 | Protein levels | B / plasma cell | 51 | 3 | 15 | 23 | |
| 576 | Influenza | IMMUN000065 | 3.90 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 577 | Dementia | NEURO000019 | 3.87 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 578 | CD27/CD79B ratio | PRORT000411 | 3.87 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 579 | HBEGF/WWP2 ratio | PRORT001272 | 3.87 | Protein ratios | Myeloid | 32 | 3 | 13 | 25 | |
| 580 | ARHGAP45 levels | PROLV000138 | 3.85 | Protein levels | Vascular | 15 | 2 | 4 | 24 | |
| 581 | DCTN6/TDRKH ratio | PRORT000875 | 3.85 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 582 | FUT8/RSPO1 ratio | PRORT001188 | 3.84 | Protein ratios | Lymphocyte | 9 | 2 | 11 | 28 | |
| 583 | Neurofibromatosis | NEURO000024 | 3.82 | Neurologic | Lymphocyte | 0 | 3 | 13 | 23 | |
| 584 | EDAR/ENO2 ratio | PRORT000966 | 3.81 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 585 | Medical condition | MISCL000028 | 3.80 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 586 | FKBP5/TBCC ratio | PRORT001159 | 3.79 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 587 | LRRFIP1 levels | PROLV001235 | 3.78 | Protein levels | Vascular | 39 | 2 | 6 | 23 | |
| 588 | Cancer, Other | MALIG000023 | 3.78 | Malignancy | B / plasma cell | 0 | 2 | 12 | 21 | |
| 589 | Knee derangements | MSKEL000016 | 3.77 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 590 | Methionine metabolites | METAB000010 | 3.76 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 591 | PPT1 levels | PROLV001621 | 3.75 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 592 | CD6/EZR ratio | PRORT000484 | 3.75 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 593 | STK24/TDRKH ratio | PRORT001820 | 3.73 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 594 | Rosacea | DERMA000019 | 3.72 | Dermatologic | Lymphocyte | 37 | 2 | 14 | 19 | |
| 595 | Heme malignancy, Plasma cell | MALIG000046 | 3.72 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 596 | CDH15 levels | PROLV000372 | 3.71 | Protein levels | Hepatocyte | 22 | 2 | 5 | 12 | |
| 597 | Progesterone metabolite | METAB000072 | 3.71 | Metabolites | Hepatocyte | 13 | 1 | 6 | 18 | |
| 598 | CA13/TIA1 ratio | PRORT000272 | 3.70 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 25 | |
| 599 | CGA levels | PROLV000420 | 3.69 | Protein levels | Lymphocyte | 0 | 0 | 4 | 10 | |
| 600 | NCAN levels | PROLV001379 | 3.68 | Protein levels | Myeloid | 72 | 3 | 4 | 12 | |
| 601 | TNFRSF11A levels | PROLV002060 | 3.65 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 602 | Surgical history | MISCL000031 | 3.64 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 603 | SELPLG levels | PROLV001806 | 3.64 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 604 | Cirrhosis | HPBIL000006 | 3.63 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 605 | CD5L levels | PROLV000348 | 3.62 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 606 | CLEC4G/NELL2 ratio | PRORT000662 | 3.62 | Protein ratios | Myeloid | 35 | 5 | 16 | 39 | |
| 607 | FOXO3/SH2B3 ratio | PRORT001179 | 3.61 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 608 | ERBIN/LYN ratio | PRORT001049 | 3.60 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 609 | NELL1 levels | PROLV001390 | 3.60 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 610 | Thrombophlebitis | VASCU000063 | 3.59 | Vascular | Hepatocyte | 61 | 1 | 4 | 9 | |
| 611 | EPHB6/TNFRSF9 ratio | PRORT001038 | 3.59 | Protein ratios | Myeloid | 23 | 3 | 15 | 47 | |
| 612 | PMVK/RHOC ratio | PRORT001694 | 3.58 | Protein ratios | Vascular | 0 | 2 | 9 | 10 | |
| 613 | EDAR/TXNDC5 ratio | PRORT000984 | 3.58 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 614 | Adjustment disorder | PSYCH000051 | 3.57 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 615 | EREG/HBEGF ratio | PRORT001055 | 3.57 | Protein ratios | Myeloid | 47 | 2 | 7 | 9 | |
| 616 | Sacroiliitis | MSKEL000020 | 3.53 | Musculoskeletal | Muscle / cardiac | 35 | 4 | 9 | 31 | |
| 617 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 3.53 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 618 | Commuting transport | SOCIO000004 | 3.52 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 619 | PCDH17/SEMA7A ratio | PRORT001626 | 3.52 | Protein ratios | Granulosa cell | 1 | 4 | 7 | 16 | |
| 620 | Medication, cardiovascular | VASCU000036 | 3.51 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 621 | Creativity | PSYCH000003 | 3.51 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 622 | TNFRSF6B levels | PROLV002072 | 3.51 | Protein levels | B / plasma cell | 32 | 2 | 8 | 11 | |
| 623 | Photodermatitis | DERMA000016 | 3.49 | Dermatologic | Lymphocyte | 2 | 2 | 11 | 29 | |
| 624 | SULT2A1 levels | PROLV001974 | 3.48 | Protein levels | Hepatocyte | 51 | 1 | 4 | 21 | |
| 625 | KLF4 levels | PROLV001149 | 3.48 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 626 | GFER/TRIAP1 ratio | PRORT001206 | 3.48 | Protein ratios | Granulosa cell | 1 | 4 | 6 | 22 | |
| 627 | FOXO1/NFATC1 ratio | PRORT001174 | 3.46 | Protein ratios | Muscle / cardiac | 0 | 4 | 16 | 37 | |
| 628 | Administrative status | MISCL000021 | 3.46 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 629 | Pregnancy complication, vomiting | REPRO000035 | 3.45 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 630 | Episcleritis | OPHTH000004 | 3.45 | Ophthalmic | Muscle / cardiac | 0 | 2 | 7 | 14 | |
| 631 | Immune disorder | IMMUN000086 | 3.44 | Immunologic | Myeloid | 44 | 4 | 8 | 11 | |
| 632 | DGKA levels | PROLV000616 | 3.43 | Protein levels | Lymphocyte | 0 | 1 | 10 | 32 | |
| 633 | CFD levels | PROLV000412 | 3.43 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 634 | Premalignant lesion, Cervix | MALIG000036 | 3.42 | Malignancy | Lymphocyte | 36 | 1 | 8 | 27 | |
| 635 | TTN levels | PROLV002119 | 3.42 | Protein levels | Muscle / cardiac | 13 | 2 | 10 | 23 | |
| 636 | Gestational age at birth | REPRO000040 | 3.40 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 637 | TIA1/USP8 ratio | PRORT001837 | 3.39 | Protein ratios | Hepatocyte | 12 | 3 | 11 | 37 | |
| 638 | COL1A1 levels | PROLV000485 | 3.38 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 639 | EDAR/PRDX5 ratio | PRORT000974 | 3.38 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 640 | MAD1L1/POLR2F ratio | PRORT001475 | 3.38 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 641 | KYNU levels | PROLV001170 | 3.37 | Protein levels | Hepatocyte | 83 | 4 | 9 | 24 | |
| 642 | NBN levels | PROLV001376 | 3.35 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 643 | ASGR1 levels | PROLV000151 | 3.35 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 644 | CXCL11/SDC4 ratio | PRORT000819 | 3.35 | Protein ratios | Myeloid | 15 | 4 | 10 | 19 | |
| 645 | Psychiatric care | PSYCH000015 | 3.35 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 646 | Systemic lupus erythematosus, SLE | IMMUN000020 | 3.34 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 647 | Otitis media | AUDIO000017 | 3.34 | Auditory | Myeloid | 33 | 0 | 2 | 4 | |
| 648 | Latent factor, platelet | HEMAT000036 | 3.34 | Hematologic | Myeloid | 148 | 2 | 5 | 11 | |
| 649 | RLN2 levels | PROLV001736 | 3.33 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 650 | GBP1 levels | PROLV000860 | 3.33 | Protein levels | Lymphocyte | 24 | 2 | 13 | 40 | |
| 651 | PDP1 levels | PROLV001530 | 3.33 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 652 | ENO3 levels | PROLV000707 | 3.33 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 653 | PHLDB1 levels | PROLV001550 | 3.32 | Protein levels | Myeloid | 1 | 1 | 6 | 16 | |
| 654 | BANK1/FOXO1 ratio | PRORT000204 | 3.31 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 655 | CD302/IL12A_IL12B ratio | PRORT000438 | 3.31 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 656 | CDH1 levels | PROLV000371 | 3.31 | Protein levels | Gastrointestinal epithelium | 18 | 0 | 10 | 5 | |
| 657 | LAT/PLXNA4 ratio | PRORT001425 | 3.30 | Protein ratios | Myeloid | 18 | 3 | 12 | 26 | |
| 658 | ALOX15B levels | PROLV000081 | 3.30 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 659 | ATXN10/SLC27A4 ratio | PRORT000163 | 3.28 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 660 | COVID-19 | IMMUN000054 | 3.28 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 661 | IL18 levels | PROLV001054 | 3.28 | Protein levels | Myeloid | 48 | 2 | 16 | 26 | |
| 662 | AXL/GAS6 ratio | PRORT000179 | 3.28 | Protein ratios | Myeloid | 29 | 3 | 9 | 19 | |
| 663 | ATP5IF1/DECR1 ratio | PRORT000154 | 3.28 | Protein ratios | Myeloid | 9 | 1 | 5 | 8 | |
| 664 | TCN2 levels | PROLV002004 | 3.28 | Protein levels | Myeloid | 63 | 2 | 8 | 12 | |
| 665 | ROR1/THBD ratio | PRORT001747 | 3.27 | Protein ratios | Lymphocyte | 10 | 3 | 14 | 38 | |
| 666 | F2R/ITGB1BP2 ratio | PRORT001077 | 3.27 | Protein ratios | Hematopoietic progenitor | 18 | 4 | 8 | 21 | |
| 667 | Medication, anti-asthmatic | IMMUN000082 | 3.26 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 668 | Telomere length | AGING000001 | 3.25 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 669 | C1QTNF1 levels | PROLV000224 | 3.25 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 670 | DXO levels | PROLV000665 | 3.24 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 671 | Cancer, Ovary | MALIG000024 | 3.22 | Malignancy | Gastrointestinal epithelium | 23 | 0 | 7 | 13 | |
| 672 | Family history, breast cancer | MALIG000038 | 3.22 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 673 | KAZN levels | PROLV001129 | 3.22 | Protein levels | Stromal / connective | 3 | 2 | 6 | 26 | |
| 674 | CDH17/PECAM1 ratio | PRORT000549 | 3.21 | Protein ratios | Myeloid | 16 | 1 | 11 | 17 | |
| 675 | EDA2R levels | PROLV000673 | 3.20 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 676 | CAMSAP1 levels | PROLV000260 | 3.20 | Protein levels | Myeloid | 2 | 2 | 2 | 10 | |
| 677 | ELOA/POLR2F ratio | PRORT001016 | 3.19 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 678 | PAK4 levels | PROLV001488 | 3.19 | Protein levels | Myeloid | 1 | 3 | 8 | 16 | |
| 679 | Lipid unsaturation | LIPID000079 | 3.18 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 680 | Biliverdin | HPBIL000018 | 3.18 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 681 | Deafness with mutism | AUDIO000010 | 3.17 | Auditory | Hepatocyte | 0 | 1 | 9 | 18 | |
| 682 | Passive smoking | MISCL000007 | 3.17 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 683 | MVK/SERPINE1 ratio | PRORT001565 | 3.16 | Protein ratios | Platelet | 10 | 3 | 16 | 31 | |
| 684 | CLEC4D/CLEC6A ratio | PRORT000654 | 3.15 | Protein ratios | Lymphocyte | 4 | 3 | 13 | 35 | |
| 685 | Kidney transplant | NEPHR000023 | 3.15 | Nephrourologic | Muscle / cardiac | 0 | 1 | 12 | 19 | |
| 686 | Cancer, General | MALIG000015 | 3.15 | Malignancy | Myeloid | 29 | 0 | 1 | 2 | |
| 687 | Arthropathy | MSKEL000013 | 3.14 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 688 | NPDC1/PTGDS ratio | PRORT001594 | 3.13 | Protein ratios | Vascular | 0 | 2 | 12 | 34 | |
| 689 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 3.13 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 690 | AZU1/RNASE3 ratio | PRORT000186 | 3.12 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 691 | RNF43 levels | PROLV001747 | 3.11 | Protein levels | Melanocyte | 0 | 1 | 1 | 3 | |
| 692 | NTF4 levels | PROLV001443 | 3.09 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 693 | Cereal preference | DTSUP000010 | 3.09 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 694 | Digestive system disorder | GASTR000006 | 3.08 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 695 | HLA-A levels | PROLV000972 | 3.08 | Protein levels | Myeloid | 143 | 3 | 11 | 29 | |
| 696 | Osteopenia | MSKEL000009 | 3.08 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 697 | Pre-eclampsia | VASCU000047 | 3.08 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 698 | GHR levels | PROLV000885 | 3.07 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 699 | CEP85 levels | PROLV000403 | 3.06 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 700 | Arterial thrombosis | VASCU000005 | 3.06 | Vascular | Vascular | 0 | 0 | 7 | 21 | |
| 701 | APRT/EREG ratio | PRORT000134 | 3.06 | Protein ratios | Myeloid | 4 | 2 | 11 | 23 | |
| 702 | LAT/LYN ratio | PRORT001422 | 3.05 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 703 | APEX1 levels | PROLV000114 | 3.05 | Protein levels | Muscle / cardiac | 6 | 4 | 12 | 38 | |
| 704 | ATOX1/SNAP29 ratio | PRORT000151 | 3.04 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 705 | FUT8/PDGFA ratio | PRORT001187 | 3.04 | Protein ratios | Hepatocyte | 8 | 2 | 15 | 50 | |
| 706 | Cerebral aneurysm | VASCU000004 | 3.03 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 707 | HLA-E levels | PROLV000976 | 3.01 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 708 | CACNA2D3 levels | PROLV000250 | 3.00 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 709 | CXCL10/WARS ratio | PRORT000815 | 3.00 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 710 | FXYD5/TMSB10 ratio | PRORT001196 | 2.98 | Protein ratios | Muscle / cardiac | 6 | 3 | 6 | 18 | |
| 711 | CXCL3/CXCL5 ratio | PRORT000825 | 2.98 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 712 | Tonsillar and adenoidal disorders | RESPI000040 | 2.98 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 713 | GLT25D1 levels | PROLV000899 | 2.98 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 714 | TNFRSF19 levels | PROLV002067 | 2.96 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 715 | Acylcarnitines | METAB000038 | 2.93 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 716 | ICAM1/REG1A ratio | PRORT001322 | 2.93 | Protein ratios | Myeloid | 16 | 3 | 9 | 17 | |
| 717 | Pancreatitis | HPBIL000027 | 2.91 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 718 | CCL17/CD69 ratio | PRORT000343 | 2.89 | Protein ratios | Myeloid | 13 | 4 | 18 | 47 | |
| 719 | CANT1/GSTA1 ratio | PRORT000306 | 2.89 | Protein ratios | Hepatocyte | 51 | 2 | 17 | 36 | |
| 720 | Sedentary behaviour | BEHAV000008 | 2.88 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 721 | LHPP levels | PROLV001209 | 2.88 | Protein levels | Lymphocyte | 19 | 2 | 14 | 44 | |
| 722 | Degenerative skin disorder | DERMA000038 | 2.88 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 723 | Cancer, Stomach | MALIG000030 | 2.88 | Malignancy | Myeloid | 2 | 0 | 1 | 9 | |
| 724 | Insulin levels | METBL000040 | 2.87 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 725 | BSG/IL12A_IL12B ratio | PRORT000247 | 2.86 | Protein ratios | B / plasma cell | 54 | 3 | 7 | 14 | |
| 726 | LBP levels | PROLV001188 | 2.85 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 727 | CD48 levels | PROLV000343 | 2.84 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 728 | Oedema | MISCL000012 | 2.84 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 729 | Non-albumin protein levels | PROLV001459 | 2.84 | Protein levels | B / plasma cell | 766 | 3 | 12 | 26 | |
| 730 | ITGB1/ITGB2 ratio | PRORT001376 | 2.83 | Protein ratios | Myeloid | 75 | 3 | 15 | 21 | |
| 731 | Enamel hypoplasia | DENTA000002 | 2.83 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 732 | DOK2/PDLIM7 ratio | PRORT000940 | 2.82 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 733 | Household composition | SOCIO000010 | 2.81 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 734 | Cancer, Liver | MALIG000018 | 2.81 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 735 | FCRL2 levels | PROLV000784 | 2.79 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 736 | CDH17/PTPRM ratio | PRORT000550 | 2.79 | Protein ratios | Lymphocyte | 10 | 1 | 14 | 25 | |
| 737 | Social activity | SOCIO000020 | 2.78 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 738 | DCTN1/TRIAP1 ratio | PRORT000874 | 2.78 | Protein ratios | Myeloid | 0 | 4 | 16 | 31 | |
| 739 | Water consumption | DTSUP000004 | 2.78 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 740 | EBAG9/HBEGF ratio | PRORT000959 | 2.78 | Protein ratios | Myeloid | 37 | 3 | 14 | 15 | |
| 741 | APBB1IP levels | PROLV000112 | 2.76 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 742 | MGAT2 levels | PROLV001308 | 2.76 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 743 | Non-cancer illness burden | MISCL000029 | 2.76 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 744 | Tyrosine | METAB000031 | 2.76 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 745 | FCRL5/MZB1 ratio | PRORT001135 | 2.74 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 746 | CCL21 levels | PROLV000288 | 2.74 | Protein levels | Lymphocyte | 35 | 1 | 4 | 11 | |
| 747 | Infertility | REPRO000010 | 2.73 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 748 | RGMB/TNFRSF21 ratio | PRORT001739 | 2.73 | Protein ratios | Myeloid | 17 | 3 | 12 | 30 | |
| 749 | GP1BA/HBEGF ratio | PRORT001225 | 2.72 | Protein ratios | Myeloid | 30 | 2 | 11 | 18 | |
| 750 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 2.72 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 751 | Educational attainment | SOCIO000002 | 2.70 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 752 | NQO2 levels | PROLV001430 | 2.70 | Protein levels | Muscle / cardiac | 22 | 1 | 6 | 13 | |
| 753 | SCARF2/TNFRSF21 ratio | PRORT001763 | 2.70 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 754 | CD69/CHMP1A ratio | PRORT000489 | 2.69 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 5 | 13 | |
| 755 | GLO1 levels | PROLV000895 | 2.69 | Protein levels | Lymphocyte | 0 | 2 | 7 | 31 | |
| 756 | Hair pigmentation | DERMA000025 | 2.69 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 757 | NUDT5/RWDD1 ratio | PRORT001609 | 2.69 | Protein ratios | Myeloid | 10 | 6 | 14 | 32 | |
| 758 | Smoking behaviour | PSYCH000046 | 2.67 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 759 | AXIN1/MAVS ratio | PRORT000175 | 2.67 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 760 | Fruit preference | DTSUP000012 | 2.66 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 761 | EBV ZEBRA antibody | IMMUN000061 | 2.66 | Immunologic | Myeloid | — | 3 | 15 | 35 | |
| 762 | APP/BIN2 ratio | PRORT000120 | 2.66 | Protein ratios | Myeloid | 3 | 2 | 13 | 34 | |
| 763 | Skin keratoses, actinic | DERMA000021 | 2.65 | Dermatologic | Lymphocyte | 211 | 2 | 10 | 23 | |
| 764 | CALCOCO1/DCTN1 ratio | PRORT000294 | 2.65 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 21 | |
| 765 | CD58/IL10RB ratio | PRORT000474 | 2.65 | Protein ratios | Myeloid | 4 | 2 | 5 | 7 | |
| 766 | ICAM4 levels | PROLV001007 | 2.64 | Protein levels | Lymphocyte | 53 | 2 | 13 | 33 | |
| 767 | AKT1S1/FHIT ratio | PRORT000064 | 2.64 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 34 | |
| 768 | FCER2/TNFRSF9 ratio | PRORT001122 | 2.63 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 769 | DHX58 levels | PROLV000617 | 2.63 | Protein levels | Hepatocyte | 1 | 4 | 9 | 28 | |
| 770 | LRIG3 levels | PROLV001228 | 2.62 | Protein levels | Lymphocyte | 0 | 0 | 9 | 20 | |
| 771 | Glycosylceramides | LIPID000069 | 2.62 | Lipids | Myeloid | 1 | 1 | 9 | 16 | |
| 772 | NT5C1A levels | PROLV001439 | 2.61 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 773 | Disability allowance | SOCIO000019 | 2.61 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 774 | PXN levels | PROLV001688 | 2.61 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 775 | Skin and soft tissue infection | IMMUN000073 | 2.57 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 776 | Exercise workload | CARDI000024 | 2.56 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 777 | PDGFA/SNAP23 ratio | PRORT001636 | 2.56 | Protein ratios | Myeloid | 9 | 2 | 15 | 16 | |
| 778 | SDCCAG8 levels | PROLV001798 | 2.56 | Protein levels | Myeloid | 1 | 2 | 3 | 12 | |
| 779 | MAN2B2 levels | PROLV001261 | 2.56 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 780 | Joint injection | MSKEL000048 | 2.56 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 781 | FOLR2/HAVCR2 ratio | PRORT001168 | 2.55 | Protein ratios | Myeloid | 79 | 5 | 20 | 28 | |
| 782 | CD84/F2R ratio | PRORT000523 | 2.54 | Protein ratios | Lymphocyte | 20 | 3 | 13 | 33 | |
| 783 | HBEGF/SDC4 ratio | PRORT001271 | 2.53 | Protein ratios | Myeloid | 56 | 2 | 9 | 18 | |
| 784 | Medication, proton pump inhibitor | GASTR000017 | 2.53 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 785 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 2.51 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 786 | BCR/GOPC ratio | PRORT000225 | 2.50 | Protein ratios | Hepatocyte | 4 | 3 | 10 | 33 | |
| 787 | CXCL11/VTA1 ratio | PRORT000820 | 2.50 | Protein ratios | Hepatocyte | 5 | 3 | 12 | 26 | |
| 788 | BLMH/SERPINE1 ratio | PRORT000237 | 2.50 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 789 | FCRL1/TREML2 ratio | PRORT001128 | 2.48 | Protein ratios | B / plasma cell | 34 | 2 | 6 | 24 | |
| 790 | ITGAM/ITGAV ratio | PRORT001375 | 2.48 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 791 | LAYN/PTPRN2 ratio | PRORT001433 | 2.48 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 792 | TIMP4 levels | PROLV002040 | 2.47 | Protein levels | Myeloid | 28 | 1 | 4 | 6 | |
| 793 | F2R levels | PROLV000745 | 2.47 | Protein levels | Lymphocyte | 23 | 2 | 5 | 21 | |
| 794 | USP8/WASF1 ratio | PRORT001858 | 2.47 | Protein ratios | Myeloid | 1 | 3 | 8 | 12 | |
| 795 | FEN1 levels | PROLV000789 | 2.47 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 796 | F11R/SORT1 ratio | PRORT001074 | 2.46 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 28 | |
| 797 | Employment status | SOCIO000005 | 2.46 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 798 | Emphysema | RESPI000011 | 2.45 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 799 | RPE levels | PROLV001753 | 2.45 | Protein levels | Lymphocyte | 0 | 2 | 15 | 29 | |
| 800 | Cancer, Endometrium | MALIG000014 | 2.45 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 801 | PCBD1 levels | PROLV001502 | 2.44 | Protein levels | Hepatocyte | 64 | 4 | 17 | 39 | |
| 802 | Medical device use, CPAP | RESPI000024 | 2.44 | Respiratory | Hepatocyte | 0 | 3 | 6 | 19 | |
| 803 | KLRD1/LY9 ratio | PRORT001415 | 2.44 | Protein ratios | Myeloid | 57 | 3 | 13 | 23 | |
| 804 | Kidney failure, acute | NEPHR000012 | 2.44 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 805 | FOXO3/MAP3K5 ratio | PRORT001178 | 2.44 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 806 | EFHD1 levels | PROLV000680 | 2.42 | Protein levels | Myeloid | 0 | 1 | 6 | 12 | |
| 807 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 2.42 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 808 | TXNDC15 levels | PROLV002124 | 2.42 | Protein levels | B / plasma cell | 86 | 4 | 19 | 38 | |
| 809 | Hair and follicular disorder | DERMA000030 | 2.42 | Dermatologic | Myeloid | 0 | 0 | 2 | 14 | |
| 810 | RHOC/TBCC ratio | PRORT001741 | 2.42 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 811 | CNTNAP2 levels | PROLV000480 | 2.41 | Protein levels | Myeloid | 28 | 2 | 10 | 16 | |
| 812 | PHYKPL levels | PROLV001552 | 2.41 | Protein levels | Lymphocyte | 3 | 2 | 6 | 16 | |
| 813 | Addison disease | ENDOC000001 | 2.41 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 814 | PSME2 levels | PROLV001659 | 2.41 | Protein levels | Vascular | 1 | 4 | 9 | 30 | |
| 815 | ATP5IF1/FIS1 ratio | PRORT000156 | 2.40 | Protein ratios | Myeloid | 28 | 3 | 11 | 12 | |
| 816 | Brain structural connectivity | NIMAG000007 | 2.40 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 817 | ATP5IF1/F2R ratio | PRORT000155 | 2.40 | Protein ratios | Myeloid | 14 | 4 | 7 | 15 | |
| 818 | Heme malignancy, Myeloid | MALIG000045 | 2.39 | Malignancy | Hepatocyte | 0 | 1 | 6 | 15 | |
| 819 | PTPRS levels | PROLV001681 | 2.39 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 820 | Myo-inositol | METAB000036 | 2.39 | Metabolites | Lymphocyte | 0 | 1 | 10 | 27 | |
| 821 | Spondylosis | MSKEL000081 | 2.39 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 822 | CEP43/USP8 ratio | PRORT000602 | 2.38 | Protein ratios | Myeloid | 0 | 2 | 8 | 27 | |
| 823 | Spondylopathy | MSKEL000080 | 2.38 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 824 | Legume preference | DTSUP000014 | 2.38 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 825 | Male genital disorder | REPRO000013 | 2.37 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 826 | CD40/ITGB5 ratio | PRORT000445 | 2.37 | Protein ratios | Myeloid | 8 | 2 | 9 | 17 | |
| 827 | Chronic bronchitis | RESPI000010 | 2.37 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 828 | HSPB6 levels | PROLV000998 | 2.37 | Protein levels | Muscle / cardiac | 7 | 4 | 10 | 26 | |
| 829 | CSF1 levels | PROLV000536 | 2.37 | Protein levels | Stromal / connective | 132 | 5 | 12 | 20 | |
| 830 | LAIR2 levels | PROLV001177 | 2.37 | Protein levels | Lymphocyte | 49 | 2 | 12 | 22 | |
| 831 | PIKFYVE levels | PROLV001559 | 2.36 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 832 | S100A11 levels | PROLV001766 | 2.36 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 833 | CD27/ICAM3 ratio | PRORT000414 | 2.35 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 834 | Prospective memory | PSYCH000009 | 2.34 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 835 | F2R/TNFRSF14 ratio | PRORT001085 | 2.34 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 836 | Rotator cuff injury | MSKEL000067 | 2.33 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 837 | Peripheral nerve disorder | NEURO000031 | 2.33 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 838 | GLOD4/HSPA1A ratio | PRORT001218 | 2.33 | Protein ratios | Myeloid | 20 | 4 | 13 | 19 | |
| 839 | CDA levels | PROLV000365 | 2.33 | Protein levels | Lymphocyte | 42 | 2 | 13 | 28 | |
| 840 | SMOC2 levels | PROLV001900 | 2.33 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 841 | Alcoholic liver disease | HPBIL000033 | 2.33 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 842 | Weight change | BMORP000016 | 2.32 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 843 | S100A12 levels | PROLV001767 | 2.32 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 844 | Spondyloarthritis | IMMUN000044 | 2.32 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 845 | Enthesopathy | MSKEL000061 | 2.31 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 846 | Dietary pattern | DTSUP000007 | 2.31 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 847 | Personal medical history | MISCL000011 | 2.31 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 848 | CDH6 levels | PROLV000377 | 2.31 | Protein levels | Hepatocyte | 17 | 3 | 12 | 29 | |
| 849 | Copper | METAB000045 | 2.31 | Metabolites | Muscle / cardiac | 0 | 3 | 6 | 21 | |
| 850 | Polymyalgia rheumatica | IMMUN000038 | 2.30 | Immunologic | Myeloid | 34 | 3 | 11 | 14 | |
| 851 | Viral wart | IMMUN000079 | 2.29 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 852 | CFHR1 levels | PROLV000414 | 2.28 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 853 | FST/FSTL3 ratio | PRORT001180 | 2.28 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 854 | Neutrophil | HEMAT000034 | 2.28 | Hematologic | Myeloid | 2,361 | 4 | 8 | 13 | |
| 855 | Cervicobrachial syndrome | MSKEL000073 | 2.27 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 856 | PCDH1 levels | PROLV001504 | 2.27 | Protein levels | Hepatocyte | 21 | 3 | 8 | 14 | |
| 857 | CXCL5/SERPINE1 ratio | PRORT000832 | 2.26 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 858 | CEP43/PLXNB3 ratio | PRORT000600 | 2.26 | Protein ratios | Myeloid | 0 | 3 | 9 | 30 | |
| 859 | GHRL levels | PROLV000886 | 2.25 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 860 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 2.24 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 861 | KCTD5 levels | PROLV001131 | 2.24 | Protein levels | Lymphocyte | 3 | 1 | 12 | 19 | |
| 862 | MAVS/SCAMP3 ratio | PRORT001500 | 2.23 | Protein ratios | Neural / glial | 0 | 1 | 6 | 22 | |
| 863 | HbA1c | METBL000039 | 2.23 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 864 | ICAM3 levels | PROLV001006 | 2.22 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 865 | REN levels | PROLV001723 | 2.22 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 866 | TNFSF12/TNFSF13 ratio | PRORT001856 | 2.22 | Protein ratios | Lymphocyte | 20 | 2 | 13 | 35 | |
| 867 | HNRNPUL1 levels | PROLV000983 | 2.21 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 868 | ATOX1/TMSB10 ratio | PRORT000153 | 2.21 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 869 | Consultant specialty, dermatology | DERMA000005 | 2.21 | Dermatologic | B / plasma cell | 5 | 0 | 2 | 9 | |
| 870 | Parental longevity | AGING000003 | 2.21 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 871 | CHCHD6 levels | PROLV000425 | 2.20 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 872 | PADI4 levels | PROLV001484 | 2.20 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 873 | Restless legs syndrome, RLS | NEURO000012 | 2.20 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 874 | BAX/MAX ratio | PRORT000205 | 2.19 | Protein ratios | Myeloid | 0 | 2 | 7 | 12 | |
| 875 | CKAP4/TNFRSF4 ratio | PRORT000624 | 2.19 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 876 | Meniscus surgery | MSKEL000050 | 2.18 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 877 | PPME1/PSMD9 ratio | PRORT001700 | 2.18 | Protein ratios | Hepatocyte | 3 | 3 | 13 | 27 | |
| 878 | GP5 levels | PROLV000916 | 2.17 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 879 | IRAK1/SPRY2 ratio | PRORT001369 | 2.17 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 880 | FAM3B/FGF19 ratio | PRORT001111 | 2.17 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 881 | DAG1/HBEGF ratio | PRORT000848 | 2.17 | Protein ratios | Myeloid | 61 | 2 | 10 | 15 | |
| 882 | METAP1D/PLXNA4 ratio | PRORT001521 | 2.17 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 883 | RND3 levels | PROLV001743 | 2.17 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 884 | BCL2L15 levels | PROLV000188 | 2.16 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 885 | CD72 levels | PROLV000354 | 2.16 | Protein levels | B / plasma cell | 84 | 2 | 12 | 31 | |
| 886 | FOLH1 levels | PROLV000821 | 2.16 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 887 | CD200R1/CLEC4G ratio | PRORT000394 | 2.16 | Protein ratios | Myeloid | 11 | 4 | 15 | 25 | |
| 888 | SIGLEC1 levels | PROLV001859 | 2.15 | Protein levels | Myeloid | 115 | 3 | 13 | 17 | |
| 889 | Liver fibrosis and cirrhosis | HPBIL000007 | 2.14 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 890 | ROR1/TNFRSF21 ratio | PRORT001748 | 2.14 | Protein ratios | Lymphocyte | 8 | 5 | 11 | 19 | |
| 891 | MMP8/PGLYRP1 ratio | PRORT001544 | 2.14 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 892 | Physical activity | BEHAV000007 | 2.14 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 893 | Family history, skin cancer | MALIG000040 | 2.13 | Malignancy | B / plasma cell | 8 | 0 | 3 | 9 | |
| 894 | ESAM/FUT8 ratio | PRORT001061 | 2.13 | Protein ratios | Lymphocyte | 3 | 2 | 13 | 24 | |
| 895 | QPCT levels | PROLV001693 | 2.13 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 896 | EIF2AK2 levels | PROLV000693 | 2.13 | Protein levels | Myeloid | 3 | 2 | 8 | 17 | |
| 897 | ADGRE5/SEMA7A ratio | PRORT000033 | 2.12 | Protein ratios | Myeloid | 18 | 2 | 6 | 13 | |
| 898 | GIMAP7 levels | PROLV000887 | 2.12 | Protein levels | Lymphocyte | 26 | 2 | 10 | 41 | |
| 899 | AXIN1/SRPK2 ratio | PRORT000177 | 2.11 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 900 | CD22/SEMA7A ratio | PRORT000403 | 2.11 | Protein ratios | B / plasma cell | 54 | 3 | 10 | 26 | |
| 901 | Biliary cirrhosis | HPBIL000005 | 2.10 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 902 | F2R/SERPINE1 ratio | PRORT001081 | 2.10 | Protein ratios | Myeloid | 15 | 3 | 12 | 20 | |
| 903 | SLAMF1 levels | PROLV001875 | 2.10 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 904 | Immune cell marker, B cell | HEMAT000021 | 2.09 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 905 | GZMA/IL12A_IL12B ratio | PRORT001259 | 2.08 | Protein ratios | B / plasma cell | 51 | 3 | 7 | 8 | |
| 906 | Sciatica | NEURO000033 | 2.08 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 907 | SNX15 levels | PROLV001911 | 2.07 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 908 | FCER2/TCL1A ratio | PRORT001121 | 2.06 | Protein ratios | B / plasma cell | 38 | 2 | 8 | 22 | |
| 909 | CCL22 levels | PROLV000289 | 2.06 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 910 | Iris and ciliary body disorder | OPHTH000005 | 2.06 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 911 | Plant sterols | METAB000074 | 2.05 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 912 | DSG2 levels | PROLV000655 | 2.05 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 913 | Wellbeing | PSYCH000056 | 2.05 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 914 | Ascites | HPBIL000020 | 2.05 | Hepatopancreatobiliary | Vascular | 1 | 1 | 7 | 23 | |
| 915 | C9 levels | PROLV000238 | 2.03 | Protein levels | Hepatocyte | 88 | 3 | 12 | 21 | |
| 916 | BST2 levels | PROLV000216 | 2.03 | Protein levels | Myeloid | 103 | 2 | 6 | 18 | |
| 917 | DARS1/EIF4B ratio | PRORT000858 | 2.03 | Protein ratios | Hepatocyte | 0 | 3 | 8 | 30 | |
| 918 | Ventricular outflow tract obstruction | CARDI000032 | 2.02 | Cardiac | Muscle / cardiac | 0 | 2 | 13 | 27 | |
| 919 | PGR levels | PROLV001548 | 2.02 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 920 | PACS2 levels | PROLV001482 | 2.02 | Protein levels | Stromal / connective | 1 | 1 | 5 | 25 | |
| 921 | Basophil | HEMAT000029 | 2.02 | Hematologic | Myeloid | 728 | 2 | 8 | 13 | |
| 922 | METAP2/RILP ratio | PRORT001525 | 2.02 | Protein ratios | Myeloid | 0 | 3 | 11 | 18 | |
| 923 | PTPRM/SELE ratio | PRORT001723 | 2.01 | Protein ratios | Granulosa cell | 2 | 1 | 6 | 14 | |
| 924 | CD28 levels | PROLV000327 | 2.01 | Protein levels | B / plasma cell | 26 | 1 | 10 | 17 | |
| 925 | Fatty acids metabolites | METAB000052 | 2.01 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 926 | Pain, joint | MSKEL000036 | 2.01 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 927 | Taurine metabolites | METAB000014 | 2.01 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 928 | SSNA1 levels | PROLV001950 | 2.00 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 929 | Goitre | ENDOC000019 | 2.00 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 930 | CD69/PLXNB3 ratio | PRORT000495 | 2.00 | Protein ratios | Myeloid | 0 | 3 | 8 | 16 | |
| 931 | AP3B1 levels | PROLV000111 | 2.00 | Protein levels | Stromal / connective | 3 | 2 | 6 | 12 | |
| 932 | GRSF1 levels | PROLV000936 | 1.99 | Protein levels | Myeloid | 3 | 3 | 9 | 10 | |
| 933 | FABP5/PPCDC ratio | PRORT001102 | 1.99 | Protein ratios | Stromal / connective | 1 | 4 | 5 | 12 | |
| 934 | Pain, chronic | MSKEL000034 | 1.98 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 935 | EPPK1 levels | PROLV000722 | 1.98 | Protein levels | Myeloid | 14 | 3 | 7 | 14 | |
| 936 | Immune cell marker, Monocyte | HEMAT000027 | 1.98 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 937 | LGALS9/SIGLEC1 ratio | PRORT001456 | 1.98 | Protein ratios | Myeloid | 15 | 3 | 13 | 17 | |
| 938 | Vehicle ownership | SOCIO000015 | 1.97 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 939 | RNASE3 levels | PROLV001738 | 1.96 | Protein levels | Myeloid | 39 | 4 | 15 | 28 | |
| 940 | LSP1 levels | PROLV001238 | 1.96 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 941 | FAS levels | PROLV000770 | 1.95 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 942 | S100A11/SERPINB8 ratio | PRORT001754 | 1.94 | Protein ratios | Myeloid | 17 | 3 | 8 | 13 | |
| 943 | CD40 levels | PROLV000340 | 1.94 | Protein levels | Platelet | 9 | 1 | 2 | 4 | |
| 944 | SPINK2 levels | PROLV001928 | 1.94 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 945 | Pre-existing hypertension, pregnancy | VASCU000044 | 1.94 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 946 | CRADD/EDAR ratio | PRORT000743 | 1.93 | Protein ratios | Myeloid | 37 | 4 | 5 | 13 | |
| 947 | IPCEF1/SERPINE1 ratio | PRORT001361 | 1.92 | Protein ratios | Lymphocyte | 4 | 4 | 13 | 41 | |
| 948 | POF1B levels | PROLV001597 | 1.92 | Protein levels | Myeloid | 7 | 3 | 17 | 20 | |
| 949 | GOLGA3 levels | PROLV000908 | 1.91 | Protein levels | Stromal / connective | 0 | 3 | 3 | 8 | |
| 950 | Sodium | METAB000050 | 1.90 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 951 | Clonal haematopoiesis | HEMAT000015 | 1.90 | Hematologic | Myeloid | 54 | 2 | 3 | 15 | |
| 952 | F2R/TMSB10 ratio | PRORT001084 | 1.89 | Protein ratios | Myeloid | 9 | 1 | 7 | 10 | |
| 953 | Herpes zoster | IMMUN000064 | 1.89 | Immunologic | Lymphocyte | 0 | 1 | 3 | 11 | |
| 954 | EDAR/TMSB10 ratio | PRORT000981 | 1.88 | Protein ratios | Myeloid | 30 | 2 | 4 | 7 | |
| 955 | Obesity | METBL000008 | 1.88 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 956 | GIPC2 levels | PROLV000888 | 1.87 | Protein levels | Hepatocyte | 4 | 2 | 5 | 11 | |
| 957 | GLRX2 levels | PROLV000897 | 1.87 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 958 | CD86 levels | PROLV000360 | 1.87 | Protein levels | Myeloid | 72 | 5 | 16 | 20 | |
| 959 | DNMBP levels | PROLV000640 | 1.86 | Protein levels | Vascular | 2 | 1 | 3 | 9 | |
| 960 | Epigenetic age acceleration | AGING000002 | 1.86 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 961 | ITGB2 levels | PROLV001113 | 1.86 | Protein levels | Myeloid | 155 | 2 | 18 | 27 | |
| 962 | FKBP1B/TGFB1 ratio | PRORT001152 | 1.85 | Protein ratios | Myeloid | 4 | 3 | 12 | 26 | |
| 963 | PLXDC1 levels | PROLV001583 | 1.85 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 964 | RAPGEF2 levels | PROLV001705 | 1.85 | Protein levels | Stromal / connective | 2 | 2 | 17 | 40 | |
| 965 | SELP/VSIR ratio | PRORT001770 | 1.85 | Protein ratios | Myeloid | 2 | 2 | 7 | 10 | |
| 966 | CD38/IL12A_IL12B ratio | PRORT000439 | 1.85 | Protein ratios | Myeloid | 70 | 3 | 7 | 11 | |
| 967 | Lysine metabolites | METAB000009 | 1.85 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 968 | ICAM3/TNFRSF13B ratio | PRORT001329 | 1.85 | Protein ratios | B / plasma cell | 40 | 1 | 7 | 6 | |
| 969 | C4 levels | PROLV000233 | 1.84 | Protein levels | Vascular | 4 | 0 | 3 | 8 | |
| 970 | SLITRK2 levels | PROLV001889 | 1.83 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 971 | HTRA2/SIAE ratio | PRORT001311 | 1.83 | Protein ratios | Lymphocyte | 8 | 5 | 13 | 32 | |
| 972 | FASLG levels | PROLV000771 | 1.83 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 973 | Keloid and scarring | DERMA000041 | 1.83 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 974 | MSTN levels | PROLV001345 | 1.83 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 975 | NELL2/SEZ6L ratio | PRORT001585 | 1.82 | Protein ratios | Lymphocyte | 2 | 4 | 16 | 31 | |
| 976 | PTP4A3 levels | PROLV001670 | 1.82 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 977 | CCL5/SELP ratio | PRORT000358 | 1.82 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 978 | S100P levels | PROLV001773 | 1.82 | Protein levels | Myeloid | 20 | 4 | 10 | 14 | |
| 979 | TNFSF14 levels | PROLV002080 | 1.82 | Protein levels | Myeloid | 15 | 2 | 6 | 24 | |
| 980 | CD40LG/TRAF2 ratio | PRORT000455 | 1.81 | Protein ratios | Lymphocyte | 4 | 2 | 13 | 45 | |
| 981 | CA1 levels | PROLV000239 | 1.81 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 982 | TP53I3 levels | PROLV002091 | 1.80 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 983 | GABBR2 levels | PROLV000845 | 1.80 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 984 | SCGB1A1 levels | PROLV001786 | 1.80 | Protein levels | Respiratory epithelium | 54 | 0 | 2 | 7 | |
| 985 | Reproductive timing | BEHAV000011 | 1.80 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 986 | NADK levels | PROLV001370 | 1.80 | Protein levels | Myeloid | 42 | 2 | 7 | 16 | |
| 987 | Negative affect | PSYCH000030 | 1.79 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 988 | Intelligence decline | PSYCH000005 | 1.79 | Psychiatric | Lymphocyte | 0 | 4 | 10 | 39 | |
| 989 | CALCA levels | PROLV000255 | 1.79 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 990 | Pregnancy complication, abortive | REPRO000027 | 1.79 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 991 | FAM3B/GPA33 ratio | PRORT001113 | 1.78 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 992 | CRYBB1 levels | PROLV000532 | 1.78 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 993 | HEPH levels | PROLV000963 | 1.78 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 994 | SDC4 levels | PROLV001797 | 1.78 | Protein levels | Hematopoietic progenitor | 103 | 3 | 7 | 20 | |
| 995 | LAYN/ULBP2 ratio | PRORT001435 | 1.78 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 996 | ENO2/PRSS27 ratio | PRORT001028 | 1.77 | Protein ratios | Myeloid | 0 | 2 | 7 | 30 | |
| 997 | CDKN2D/FOXO1 ratio | PRORT000577 | 1.77 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 998 | Hair characteristics | DERMA000031 | 1.76 | Dermatologic | Adipose | 1 | 1 | 1 | 0 | |
| 999 | GBA1 levels | PROLV000859 | 1.76 | Protein levels | Myeloid | 0 | 2 | 8 | 20 | |
| 1000 | ADHD | PSYCH000033 | 1.76 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 |